Dupilumab Treatment Shows Rapid and Consistent Improvement in Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 17 Years: Results From an Open-Label Extension Study
Autoren
Elaine C. Siegfried
Sebastian Straub
Sanofi-Aventis (Schweiz) AG
Vortragender